Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Heart Failure

  Free Subscription

Articles published in
J Am Coll Cardiol
    September 2021
  1. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
    Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1166-1187.
    >> Share

    August 2021
  2. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
    Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:931-956.
    >> Share

  3. HERSBERGER L, Stanga Z, Schuetz P
    Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:856-857.
    >> Share

  4. IKOMA T, Saito H, Oka T, Maekawa Y, et al
    The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:855-856.
    >> Share

  5. DROZD M, Cubbon RM
    Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
    J Am Coll Cardiol. 2021;78:760.
    >> Share

  6. SHEN L, Jhund PS, McMurray JJV
    Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
    J Am Coll Cardiol. 2021;78:760-761.
    >> Share

  7. MEWTON N, Baudry G, Sebbag L
    Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
    J Am Coll Cardiol. 2021;78:759.
    >> Share

  8. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
    Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637-638.
    >> Share

  9. DEL BUONO MG, Van Tassell BW, Abbate A
    Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637.
    >> Share

  10. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
    Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
    J Am Coll Cardiol. 2021;78:543-544.
    >> Share

  11. SHCHENDRYGINA A, Mewton N, Meznar AZ
    Advanced Heart Failure and Angiotensin System Fascinating Complexities.
    J Am Coll Cardiol. 2021;78:541-542.
    >> Share

    July 2021
  12. ROSSIGNOL P, Pitt B
    Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
    J Am Coll Cardiol. 2021;78:344-347.
    >> Share

  13. ITKIN M, Rockson SG, Burkhoff D
    Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:278-290.
    >> Share

  14. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    >> Share

  15. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    >> Share

  16. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    >> Share

  17. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
    Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
    J Am Coll Cardiol. 2021;78:14-23.
    >> Share

    June 2021
  18. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    >> Share

  19. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    >> Share

  20. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    >> Share

  21. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
    Pericardial Fat and the Risk of Heart Failure.
    J Am Coll Cardiol. 2021;77:2638-2652.
    >> Share

    May 2021
  22. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    >> Share

  23. GOTTLIEB SH
    Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
    J Am Coll Cardiol. 2021;77:2320-2322.
    >> Share

  24. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
    Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
    J Am Coll Cardiol. 2021;77:2307-2319.
    >> Share

  25. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
    New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
    J Am Coll Cardiol. 2021;77:2260-2262.
    >> Share

  26. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
    Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
    >> Share

    April 2021
  27. MANCINI D, Gibson GT
    Impact of Pneumonia in Heart Failure Patients.
    J Am Coll Cardiol. 2021;77:1974-1976.
    >> Share

  28. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
    Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1961-1973.
    >> Share

  29. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
    Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1952-1953.
    >> Share

  30. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    >> Share

  31. RAUH MJ
    Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2021;77:1760-1762.
    >> Share

  32. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
    Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1747-1759.
    >> Share

  33. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
    Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    J Am Coll Cardiol. 2021;77:1731-1743.
    >> Share

    March 2021
  34. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
    Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    J Am Coll Cardiol. 2021;77:1454-1469.
    >> Share

  35. GREENE SJ, Khan MS
    Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
    J Am Coll Cardiol. 2021;77:1408-1411.
    >> Share

  36. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
    Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
    J Am Coll Cardiol. 2021;77:1397-1407.
    >> Share

  37. KOSIBOROD MN, Vaduganathan M
    SGLT-2 Inhibitors in Heart Failure: Volume or Value?
    J Am Coll Cardiol. 2021;77:1393-1396.
    >> Share

  38. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;77:1381-1392.
    >> Share

  39. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
    SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
    J Am Coll Cardiol. 2021;77:1375-1377.
    >> Share

  40. MCCULLOUGH PA, Rahimi G, Tecson KM
    Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1222-1224.
    >> Share

  41. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
    Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    J Am Coll Cardiol. 2021;77:1211-1221.
    >> Share

  42. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    >> Share

    February 2021
  43. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    >> Share

  44. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.
    >> Share

  45. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    >> Share

  46. GOODLIN SJ
    RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
    J Am Coll Cardiol. 2021;77:504-505.
    >> Share

  47. CHUZI S, Khan SS, Pak ES
    Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
    J Am Coll Cardiol. 2021;77:501-505.
    >> Share

  48. FRISK M, Le C, Shen X, Roe AT, et al
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:405-419.
    >> Share

  49. HULOT JS, Livrozet M
    HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
    J Am Coll Cardiol. 2021;77:420-422.
    >> Share

    January 2021
  50. GOLDBERG LR
    The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
    J Am Coll Cardiol. 2021;77:256-258.
    >> Share

  51. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
    Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
    >> Share

  52. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
    J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
    >> Share

    December 2020
  53. PAGANI FD
    Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
    J Am Coll Cardiol. 2020;76:2965-2967.
    >> Share

  54. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
    Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    J Am Coll Cardiol. 2020;76:2940-2951.
    >> Share

  55. ALAHMAD B, Khraishah H
    Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
    J Am Coll Cardiol. 2020;76:2875-2877.
    >> Share

  56. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
    Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
    J Am Coll Cardiol. 2020;76:2862-2874.
    >> Share

  57. GUPTA DK, Crescenzi R, Aday AW
    Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2830-2833.
    >> Share

  58. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
    Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2817-2829.
    >> Share

  59. JANUZZI JL JR, Ibrahim NE
    Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
    J Am Coll Cardiol. 2020;76:2752-2754.
    >> Share

  60. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
    Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2740-2751.
    >> Share

  61. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
    Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:2671-2681.
    >> Share

  62. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
    Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:2595-2606.
    >> Share

    November 2020
  63. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
    2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
    >> Share

  64. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
    Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
    J Am Coll Cardiol. 2020;76:2334-2348.
    >> Share

  65. FASELIS C, Fonarow GC, Ahmed A
    Reply: Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418-2420.
    >> Share

  66. DAUW J, Mullens W
    Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418.
    >> Share

  67. PANJRATH GS, Krepp J
    COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
    J Am Coll Cardiol. 2020;76:2349-2351.
    >> Share

  68. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.
    >> Share

  69. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.
    >> Share

  70. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    >> Share

  71. VELAZQUEZ EJ, Reinhardt SW
    Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
    J Am Coll Cardiol. 2020;76:2086-2088.
    >> Share

    October 2020
  72. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
    Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2040-2041.
    >> Share

  73. FUDIM M, Soloveva A
    Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2038-2039.
    >> Share

  74. LIU PP, Al-Khalaf M, Blet A
    Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
    J Am Coll Cardiol. 2020;76:1995-1998.
    >> Share

  75. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1982-1994.
    >> Share

  76. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
    Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    J Am Coll Cardiol. 2020;76:1919-1930.
    >> Share

  77. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
    2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
    >> Share

  78. KITTLESON MM
    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.
    >> Share

  79. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
    Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1795-1807.
    >> Share

  80. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
    Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
    J Am Coll Cardiol. 2020;76:1717-1718.
    >> Share

  81. MEWTON N, Sebbag L, Bochaton T
    Other Things Behind the Low Rate of Heart Failure Trial Publication.
    J Am Coll Cardiol. 2020;76:1716-1717.
    >> Share

  82. MEHMOOD M
    Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
    J Am Coll Cardiol. 2020;76:1715-1716.
    >> Share

    September 2020
  83. SUTHAHAR N, Lau ES, Blaha MJ, Paniagua SM, et al
    Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure.
    J Am Coll Cardiol. 2020;76:1455-1465.
    >> Share

  84. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
    Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
    J Am Coll Cardiol. 2020;76:1501-1502.
    >> Share

  85. XIANG D, Xiang X, Zhang W, Yi S, et al
    Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.
    J Am Coll Cardiol. 2020;76:1318-1324.
    >> Share

  86. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
    Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:1305-1314.
    >> Share

  87. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    >> Share

  88. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    >> Share

  89. AMBROSY AP, Braunwald E, Morrow DA, DeVore AD, et al
    Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists.
    J Am Coll Cardiol. 2020;76:1034-1048.
    >> Share

  90. GOTTLIEB SS, Ahmed T
    Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
    J Am Coll Cardiol. 2020;76:1049-1050.
    >> Share

  91. GUAZZI M, Ghio S, Adir Y
    Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1102-1111.
    >> Share

  92. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
    Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;76:1084-1101.
    >> Share

    August 2020
  93. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
    Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    J Am Coll Cardiol. 2020;76:930-941.
    >> Share

  94. SANNINO A, Sudhakaran S, Milligan G, Chowdhury A, et al
    Effectiveness of Medical Therapy for Functional Mitral Regurgitation in Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:883-884.
    >> Share

  95. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    >> Share

  96. ROWIN EJ, Maron BJ, Maron MS
    The LVAD in the Management of Advanced Heart Failure Due to Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36310.
    >> Share

  97. DALZELL JR, Connolly EC, Cannon JA
    The LVAD in the management of advanced heart failure due to hypertrophic cardiomyopathy.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36312.
    >> Share

  98. BUTLER J, Khan MS
    Heart Failure Prevention for All: Treatment Is Good, Prevention Is Better.
    J Am Coll Cardiol. 2020 Aug 14. pii: S0735-1097(20)36305.
    >> Share

  99. WILCOX JE, Fang JC, Margulies KB, Mann DL, et al
    Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2020;76:719-734.
    >> Share

  100. FASELIS C, Arundel C, Patel S, Lam PH, et al
    Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    J Am Coll Cardiol. 2020;76:669-679.
    >> Share

  101. COX ZL, Stevenson LW
    The Weight of Evidence for Diuretics and Parachutes.
    J Am Coll Cardiol. 2020;76:680-683.
    >> Share

  102. BAYES-GENIS A, Nunez J, Lupon J
    Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
    J Am Coll Cardiol. 2020;76:515-517.
    >> Share

  103. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
    Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
    J Am Coll Cardiol. 2020;76:503-514.
    >> Share

    July 2020
  104. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    >> Share

  105. ZILE MR, Lindenfeld J, Weaver FA, Zannad F, et al
    Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1-13.
    >> Share

  106. JANUZZI JL JR, Ibrahim NE
    The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
    J Am Coll Cardiol. 2020;76:14-16.
    >> Share

    June 2020
  107. PSOTKA MA, Latta F, Cani D, Fiuzat M, et al
    Publication Rates of Heart Failure Clinical Trials Remain Low.
    J Am Coll Cardiol. 2020;75:3151-3161.
    >> Share

  108. MEHRA MR, Grazette LP
    Untimely Trial Publication: A Sin of Omission?
    J Am Coll Cardiol. 2020;75:3162-3163.
    >> Share

  109. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
    Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    J Am Coll Cardiol. 2020;75:3033-3043.
    >> Share

  110. KAPUR NK
    RESPONSE: Hybrid Training for Interventional, Heart Failure, and Critical Care Medicine.
    J Am Coll Cardiol. 2020;75:2987-2988.
    >> Share

  111. SOMERS VK, Karim S
    Upright Cheyne-Stokes Respiration in Heart Failure: Look But Don't Touch.
    J Am Coll Cardiol. 2020;75:2947-2949.
    >> Share

  112. GIANNONI A, Gentile F, Sciarrone P, Borrelli C, et al
    Upright Cheyne-Stokes Respiration in Patients With Heart Failure.
    J Am Coll Cardiol. 2020;75:2934-2946.
    >> Share

  113. PARKER WF, Chung K, Anderson AS, Siegler M, et al
    Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
    J Am Coll Cardiol. 2020;75:2906-2916.
    >> Share

  114. FERREIRA JP, Butler J, Rossignol P, Pitt B, et al
    Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:2836-2850.
    >> Share

  115. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
    Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:2851-2862.
    >> Share

    May 2020
  116. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
    Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
    J Am Coll Cardiol. 2020;75:2642-2644.
    >> Share

  117. JAVAHERI A, Allegood JC, Cowart LA, Chirinos JA, et al
    Circulating Ceramide 16:0 in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:2273-2275.
    >> Share

  118. MEINERTZ T, Munzel T
    Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
    J Am Coll Cardiol. 2020;75:2107-2109.
    >> Share

    April 2020
  119. HULOT JS, Masurkar N
    miRNA-Based Therapeutics for Heart Failure: Why Not?
    J Am Coll Cardiol. 2020;75:1801-1803.
    >> Share

  120. REDFORS B, Furer A, Selker HP, Thiele H, et al
    Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    J Am Coll Cardiol. 2020;75:1743-1754.
    >> Share

    March 2020
  121. STEVENSON LW, Naftilan AJ
    Changing the Stage Directions for Heart Failure?
    J Am Coll Cardiol. 2020;75:1439-1442.
    >> Share

  122. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
    Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1501-1502.
    >> Share

  123. PALAZZUOLI A, Ruocco G
    Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1500-1501.
    >> Share

  124. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1471-1487.
    >> Share

  125. NIJST P, Martens P, Dauw J, Tang WHW, et al
    Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2020;75:1426-1438.
    >> Share

  126. MURPHY SP, Kakkar R, McCarthy CP, Januzzi JL Jr, et al
    Inflammation in Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1324-1340.
    >> Share

  127. CHIRINOS JA, Orlenko A, Zhao L, Basso MD, et al
    Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;75:1281-1295.
    >> Share

  128. ALEXANDER CM
    Is Heart Failure Still the Frequent, Forgotten, and Often Fatal Complication of Diabetes?
    J Am Coll Cardiol. 2020;75:1263-1265.
    >> Share

  129. KITZMAN DW, Upadhya B, Felker GM
    A Biomarker Approach to Understanding HFpEF.
    J Am Coll Cardiol. 2020;75:1296-1298.
    >> Share

  130. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    >> Share

  131. PIRRUCCELLO JP, Bick A, Chaffin M, Aragam KG, et al
    Titin Truncating Variants in Adults Without Known Congestive Heart Failure.
    J Am Coll Cardiol. 2020;75:1239-1241.
    >> Share

  132. FELKER GM, Ellison DH, Mullens W, Cox ZL, et al
    Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1178-1195.
    >> Share

  133. DEC GW
    Which Drug Will "Lead" in Reducing Cardiac Events Among Heart Failure Patients With Diabetes?
    J Am Coll Cardiol. 2020;75:1142-1144.
    >> Share

  134. MARSO SP, Baeres FMM, Bain SC, Goldman B, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.
    J Am Coll Cardiol. 2020;75:1128-1141.
    >> Share

  135. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
    Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
    J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
    >> Share

  136. PAULUS WJ
    Adhesion molecules in early adulthood predict heart failure with preserved ejection fraction at older age.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)34549.
    >> Share

  137. SELVARAJ S, Claggett BL, Bohm M, Anker SD, et al
    Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.
    J Am Coll Cardiol. 2020 Mar 11. pii: S0735-1097(20)30518.
    >> Share

  138. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal.
    J Am Coll Cardiol. 2020 Mar 10. pii: S0735-1097(20)30620.
    >> Share

  139. SABBATINI AR, Kararigas G
    Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:1074-1082.
    >> Share

  140. ARNOLD SV, Stone GW, Mack MJ, Chhatriwalla AK, et al
    Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.
    J Am Coll Cardiol. 2020 Mar 4. pii: S0735-1097(20)34413.
    >> Share

  141. BUGIARDINI R, Manfrini O, Cenko E
    Reply: Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:989.
    >> Share

  142. PATANE S
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction: The Role of S-Nitrosylation.
    J Am Coll Cardiol. 2020;75:988-989.
    >> Share

    February 2020
  143. KO DT, Khera R, Lau G, Qiu F, et al
    Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure.
    J Am Coll Cardiol. 2020;75:736-746.
    >> Share

  144. WASFY JH
    A Health Policy and Care Delivery Crisis That We Must Understand Then Fix.
    J Am Coll Cardiol. 2020;75:747-749.
    >> Share

  145. YANCY CW, Drazner MH, Coffin ST, Cornwell W 3rd, et al
    2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.
    J Am Coll Cardiol. 2020 Feb 14. pii: S0735-1097(19)37741.
    >> Share

  146. ZELNIKER TA, Braunwald E
    Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:422-434.
    >> Share

  147. LEE SP, Suh HY, Park S, Oh S, et al
    Pittsburgh B Compound Positron Emission Tomography in Patients With AL Cardiac Amyloidosis.
    J Am Coll Cardiol. 2020;75:380-390.
    >> Share

  148. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    >> Share

    January 2020
  149. VENTURA HO, Lavie CJ, Mehra MR
    Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff.
    J Am Coll Cardiol. 2020;75:255-257.
    >> Share

  150. GOLDHABER SZ
    Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention.
    J Am Coll Cardiol. 2020;75:159-162.
    >> Share

  151. FANOLA CL, Norby FL, Shah AM, Chang PP, et al
    Incident Heart Failure and Long-Term Risk for Venous Thromboembolism.
    J Am Coll Cardiol. 2020;75:148-158.
    >> Share

  152. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    >> Share

    December 2019
  153. DESWAL A
    Heart Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint.
    J Am Coll Cardiol. 2019;74:2905-2907.
    >> Share

  154. KOTECHA D, Gill SK, Flather MD, Holmes J, et al
    Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2893-2904.
    >> Share

  155. SHAH AM, Cikes M, Prasad N, Li G, et al
    Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2858-2873.
    >> Share

  156. FONAROW GC, Masson R, Ahmed A
    Reply: What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827-2828.
    >> Share

  157. TAN J, Mai L, Zhang Y, Wu Y, et al
    What Is Important for Digoxin Treatment in Patients With Heart Failure.
    J Am Coll Cardiol. 2019;74:2827.
    >> Share

    November 2019
  158. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    >> Share

  159. CENKO E, van der Schaar M, Yoon J, Manfrini O, et al
    Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:2379-2389.
    >> Share

  160. BRILLER J
    The Feminine Mystique in Myocardial Infarction Associated Mortality.
    J Am Coll Cardiol. 2019;74:2390-2391.
    >> Share

  161. VADUGANATHAN M, Fonarow GC, Greene SJ, DeVore AD, et al
    Health-Related Quality of Life in Comorbid Heart Failure With Reduced Ejection Fraction and Diabetes Mellitus.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38082.
    >> Share

  162. VADUGANATHAN M, Claggett BL, Desai AS, Anker SD, et al
    Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF.
    J Am Coll Cardiol. 2019 Nov 6. pii: S0735-1097(19)38299.
    >> Share

  163. MARTYN T, Faulkenberg KD, Yaranov DM, Albert CL, et al
    Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output.
    J Am Coll Cardiol. 2019;74:2326-2327.
    >> Share

  164. GIVERTZ MM, DeFilippis EM, Landzberg MJ, Pinney SP, et al
    Advanced Heart Failure Therapies for Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:2295-2312.
    >> Share

  165. CIAMPI Q, Zagatina A, Cortigiani L, Gaibazzi N, et al
    Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography.
    J Am Coll Cardiol. 2019;74:2278-2291.
    >> Share

    October 2019
  166. AIMO A, Januzzi JL Jr, Bayes-Genis A, Vergaro G, et al
    Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2193-2203.
    >> Share

  167. SUN J, Shang H, Yang X, Xing Y, et al
    Effect of Cardioprotective Drugs on Chemotherapy-Induced Heart Failure and New Risk Stratification.
    J Am Coll Cardiol. 2019;74:1736.
    >> Share

  168. GOLDSTEIN NE, Mather H, McKendrick K, Gelfman LP, et al
    Improving Communication in Heart Failure Patient Care.
    J Am Coll Cardiol. 2019;74:1682-1692.
    >> Share

    September 2019
  169. ASCH FM, Grayburn PA, Siegel RJ, Kar S, et al
    Transcatheter Mitral Valve Replacement in Patients with Heart Failure and Secondary Mitral Regurgitation: From COAPT Trial.
    J Am Coll Cardiol. 2019 Sep 19. pii: S0735-1097(19)37678.
    >> Share

  170. GREENE SJ, Fonarow GC, Butler J
    Reply: Titration of Guideline-Directed Medical Therapy Improves Patient-Centered Outcomes in Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:1426-1427.
    >> Share

  171. DIMMITT SB, Martin JH
    Clinically Optimal Versus "Target" Doses in Heart Failure.
    J Am Coll Cardiol. 2019;74:1425.
    >> Share

  172. SULLIVAN K, Mamas MA, Van Spall HGC
    Machine Learning Could Facilitate Optimal Titration of Guideline-Directed Medical Therapy in Heart Failure.
    J Am Coll Cardiol. 2019;74:1424-1425.
    >> Share

  173. CANPOLAT U
    Radial Artery Coronary Bypass Grafting in Heart Failure Patients and Calcium-Channel Blockers.
    J Am Coll Cardiol. 2019;74:1422-1423.
    >> Share

  174. HOLLENBERG SM, Warner Stevenson L, Ahmad T, Amin VJ, et al
    2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2019 Sep 10. pii: S0735-1097(19)36183.
    >> Share

  175. JANUZZI JL JR, Ahmad T, Mulder H, Coles A, et al
    Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:1205-1217.
    >> Share

    August 2019
  176. MCMURRAY JJV, Docherty KF
    Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?
    J Am Coll Cardiol. 2019;74:902-904.
    >> Share

  177. SCOTT NJA, Rademaker MT, Charles CJ, Espiner EA, et al
    Hemodynamic, Hormonal, and Renal Actions of Phosphodiesterase-9 Inhibition in Experimental Heart Failure.
    J Am Coll Cardiol. 2019;74:889-901.
    >> Share

  178. JUJIC A, Melander O, Bergmann A, Hartmann O, et al
    Selenoprotein P Deficiency and Risk of Mortality and Rehospitalization in Acute Heart Failure.
    J Am Coll Cardiol. 2019;74:1009-1011.
    >> Share

  179. TRIPOSKIADIS F, Xanthopoulos A, Butler J
    Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:804-813.
    >> Share

  180. LEONG DP, McMurray JJV, Joseph PG, Yusuf S, et al
    From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).
    J Am Coll Cardiol. 2019;74:683-698.
    >> Share

  181. JOSEPH P, Swedberg K, Leong DP, Yusuf S, et al
    The Evolution of beta-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5).
    J Am Coll Cardiol. 2019;74:672-682.
    >> Share

  182. MALIK A, Masson R, Singh S, Wu WC, et al
    Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;74:617-627.
    >> Share

  183. CHIRINOS JA
    Discerning the Age-Related Heterogeneity in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:613-616.
    >> Share

  184. TROMP J, Shen L, Jhund PS, Anand IS, et al
    Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:601-612.
    >> Share

    July 2019
  185. TAYLOR RS, Smart NA, Warren FC, Dalal HM, et al
    Reply: Exercise Capacity Characterization and Physical Activity Intensification Should Be Priorities in Heart Failure Patients.
    J Am Coll Cardiol. 2019;74:590-591.
    >> Share

  186. LEGGIO M, Tiberti C, Armeni M, Limongelli G, et al
    Exercise Capacity Characterization and Physical Activity Intensification Should Be Priorities in Heart Failure Patients.
    J Am Coll Cardiol. 2019;74:589-590.
    >> Share

  187. AIMO A, Maisel AS, Castiglione V, Emdin M, et al
    sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff?
    J Am Coll Cardiol. 2019;74:478-479.
    >> Share

  188. BALDETTI L, Gallone G, Melillo F, Pagnesi M, et al
    Another Call to Address Inflammation in Heart Failure.
    J Am Coll Cardiol. 2019;74:477-478.
    >> Share

  189. MYHRE PL, Vaduganathan M, Solomon SD
    Reply: Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI.
    J Am Coll Cardiol. 2019;74:165-166.
    >> Share

  190. KODZISZEWSKA K, Sochanowicz B, Hryniewiecki TT, Witold S, et al
    Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI.
    J Am Coll Cardiol. 2019;74:164-165.
    >> Share

  191. FOSBOL EL, Rorth R, Leicht BP, Schou M, et al
    Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.
    J Am Coll Cardiol. 2019;74:15-23.
    >> Share

    June 2019
  192. DEVORE AD, Yancy CW
    Heart Failure Management Under Pressure.
    J Am Coll Cardiol. 2019;73:3064-3066.
    >> Share

  193. ARUNDEL C, Lam PH, Gill GS, Patel S, et al
    Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:3054-3063.
    >> Share

  194. AIMO A, Emdin M, Maisel AS
    Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure.
    J Am Coll Cardiol. 2019;73:3038-3039.
    >> Share

  195. VERGARO G, Passino C, Emdin M
    No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril.
    J Am Coll Cardiol. 2019;73:3037-3038.
    >> Share

  196. RUBERG FL, Grogan M, Hanna M, Kelly JW, et al
    Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2872-2891.
    >> Share

  197. VAN DER MEER P, Gaggin HK, Dec GW
    ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison.
    J Am Coll Cardiol. 2019;73:2756-2768.
    >> Share

  198. HERZOG CA
    Congestive Heart Failure and Chronic Kidney Disease: The CardioRenal/NephroCardiology Connection.
    J Am Coll Cardiol. 2019;73:2701-2704.
    >> Share

  199. BANSAL N, Zelnick L, Bhat Z, Dobre M, et al
    Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease.
    J Am Coll Cardiol. 2019;73:2691-2700.
    >> Share

  200. SALLOUM FN, Chau VQ
    Osteopontin in HFpEF: More Than Just a Remodeling-Specific Biomarker.
    J Am Coll Cardiol. 2019;73:2719-2721.
    >> Share

  201. YOUSEFI K, Irion CI, Takeuchi LM, Ding W, et al
    Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
    J Am Coll Cardiol. 2019;73:2705-2718.
    >> Share

    May 2019
  202. BARTKO PE, Arfsten H, Heitzinger G, Pavo N, et al
    A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:2506-2517.
    >> Share

  203. CLELAND JGF, Pellicori P, Clark AL
    Prevention or Procrastination for Heart Failure?: Why We Need a Universal Definition of Heart Failure.
    J Am Coll Cardiol. 2019;73:2398-2400.
    >> Share

  204. KHAN SS, Ning H, Shah SJ, Yancy CW, et al
    10-Year Risk Equations for Incident Heart Failure in the General Population.
    J Am Coll Cardiol. 2019;73:2388-2397.
    >> Share

  205. BOZKURT B
    Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure.
    J Am Coll Cardiol. 2019;73:2384-2387.
    >> Share

  206. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    >> Share

  207. GLYNN P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, et al
    Disparities in Cardiovascular Mortality Related to Heart Failure in the United States.
    J Am Coll Cardiol. 2019;73:2354-2355.
    >> Share

  208. NAGARAJU CK, Robinson EL, Abdesselem M, Trenson S, et al
    Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.
    J Am Coll Cardiol. 2019;73:2267-2282.
    >> Share

  209. DANIELS LB, Bui QM
    Should a High Gal-3 Have Us Scared Stiff?
    J Am Coll Cardiol. 2019;73:2296-2298.
    >> Share

  210. FRANGOGIANNIS NG
    Can Myocardial Fibrosis Be Reversed?
    J Am Coll Cardiol. 2019;73:2283-2285.
    >> Share

  211. STIENEN S, Ferreira JP, Vincent J, Busselen M, et al
    Estimated Long-Term Survival With Eplerenone.
    J Am Coll Cardiol. 2019;73:2357-2359.
    >> Share

  212. PSOTKA MA, Gottlieb SS, Francis GS, Allen LA, et al
    Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2345-2353.
    >> Share

  213. ASLEH R, Enriquez-Sarano M, Jaffe AS, Manemann SM, et al
    Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    J Am Coll Cardiol. 2019;73:2286-2295.
    >> Share

  214. DEL BUONO MG, Arena R, Borlaug BA, Carbone S, et al
    Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2209-2225.
    >> Share

  215. BAYES-GENIS A, Lanfear D
    Liquid Biopsy and eHealth in Heart Failure: The Future Is Now.
    J Am Coll Cardiol. 2019;73:2206-2208.
    >> Share

  216. UPADHYAY GA, Vijayaraman P, Nayak HM, Verma N, et al
    His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure.
    J Am Coll Cardiol. 2019 May 7. pii: S0735-1097(19)34992.
    >> Share

  217. IUNG B, Messika-Zeitoun D
    Transcatheter Mitral Valve Repair in Secondary MR: New Findings and New Challenges.
    J Am Coll Cardiol. 2019;73:2133-2134.
    >> Share

  218. WELLS QS, Gupta DK, Smith JG, Collins SP, et al
    Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.
    J Am Coll Cardiol. 2019;73:2195-2205.
    >> Share

  219. SCHLICHTING LE, Insaf TZ, Zaidi AN, Lui GK, et al
    Maternal Comorbidities and Complications of Delivery in Pregnant Women With Congenital Heart Disease.
    J Am Coll Cardiol. 2019;73:2181-2191.
    >> Share

    April 2019
  220. WANG DD
    Dietary Patterns and Precision Prevention of Heart Failure.
    J Am Coll Cardiol. 2019;73:2046-2048.
    >> Share

  221. LARA KM, Levitan EB, Gutierrez OM, Shikany JM, et al
    Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
    J Am Coll Cardiol. 2019;73:2036-2045.
    >> Share

  222. SANTOS-GALLEGO CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, et al
    Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
    J Am Coll Cardiol. 2019;73:1931-1944.
    >> Share

  223. LEHRKE M
    SGLT2 Inhibition: Changing What Fuels the Heart.
    J Am Coll Cardiol. 2019;73:1945-1947.
    >> Share

  224. HAUSENLOY DJ, Heusch G
    Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.
    J Am Coll Cardiol. 2019;73:2001-2003.
    >> Share

  225. THOMAS L, Marwick TH, Popescu BA, Donal E, et al
    Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:1961-1977.
    >> Share

  226. GHORBANI A, Ho JE
    Reply: Galectin-3: A Pathophysiological Background Index or an Emerging Prognostic Biomarker in Heart Failure?
    J Am Coll Cardiol. 2019;73:1875-1876.
    >> Share

  227. OIKONOMOU E, Siasos G, Tousoulis D
    Galectin-3: A Pathophysiological Background Index or an Emerging Prognostic Biomarker in Heart Failure?
    J Am Coll Cardiol. 2019;73:1875.
    >> Share

  228. MORROW DA
    The Changing Face of Cardiogenic Shock: A Challenge in Cardiac Critical Care.
    J Am Coll Cardiol. 2019;73:1792-1794.
    >> Share

  229. LAVIE CJ, Ozemek C, Arena R
    Bringing Cardiac Rehabilitation and Exercise Training to a Higher Level in Heart Failure.
    J Am Coll Cardiol. 2019;73:1444-1446.
    >> Share

  230. TAYLOR RS, Walker S, Smart NA, Piepoli MF, et al
    Impact of Exercise Rehabilitation on Exercise Capacity and Quality-of-Life in Heart Failure: Individual Participant Meta-Analysis.
    J Am Coll Cardiol. 2019;73:1430-1443.
    >> Share

    March 2019
  231. SHAH RV, Das S, Lewis GD
    Circulating MicroRNAs: New Avenues for Heart Failure Classification?
    J Am Coll Cardiol. 2019;73:1314-1316.
    >> Share

  232. WONG LL, Zou R, Zhou L, Lim JY, et al
    Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    J Am Coll Cardiol. 2019;73:1300-1313.
    >> Share

  233. ANAND IS
    What Explains the Benefits of ARNI Therapy in Heart Failure?
    J Am Coll Cardiol. 2019;73:1285-1287.
    >> Share

  234. IBRAHIM NE, McCarthy CP, Shrestha S, Gaggin HK, et al
    Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.
    J Am Coll Cardiol. 2019;73:1273-1284.
    >> Share

  235. MYHRE PL, Vaduganathan M, Claggett B, Packer M, et al
    B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
    J Am Coll Cardiol. 2019;73:1264-1272.
    >> Share

  236. FELDMAN AM
    Precision Medicine for Heart Failure: Back to the Future.
    J Am Coll Cardiol. 2019;73:1185-1188.
    >> Share

  237. SUCHAROV CC, Nakano SJ, Slavov D, Schwisow JA, et al
    A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.
    J Am Coll Cardiol. 2019;73:1173-1184.
    >> Share

  238. GREENE SJ, Wilson LE, Abbasi SA, Yusuf AA, et al
    Outpatient Intravenous Diuretic Therapy for Heart Failure in the United States.
    J Am Coll Cardiol. 2019;73:1101-1103.
    >> Share

  239. EVERETT BM, Siddiqi HK
    Heart Failure, the Inflammasome, and Interleukin-1beta: Prognostic and Therapeutic?
    J Am Coll Cardiol. 2019;73:1026-1028.
    >> Share

  240. PASCUAL-FIGAL DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, et al
    The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure.
    J Am Coll Cardiol. 2019;73:1016-1025.
    >> Share

  241. FONAROW GC, Ziaeian B
    Hospital Readmission Reduction Program for Heart Failure: The Spread of Intended and Unintended Consequences.
    J Am Coll Cardiol. 2019;73:1013-1015.
    >> Share

  242. BLECKER S, Herrin J, Li L, Yu H, et al
    Trends in Hospital Readmission of Medicare-Covered Patients With Heart Failure.
    J Am Coll Cardiol. 2019;73:1004-1012.
    >> Share

  243. EBERLY LA, Rusingiza E, Park PH, Ngoga G, et al
    10-Year Heart Failure Outcomes From Nurse-Driven Clinics in Rural Sub-Saharan Africa.
    J Am Coll Cardiol. 2019;73:977-980.
    >> Share

  244. BUTLER J, Yang M, Manzi MA, Hess GP, et al
    Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:935-944.
    >> Share

  245. BRESS AP, King JB
    Optimizing Medical Therapy in Chronic Worsening HFrEF: A Long Way to Go.
    J Am Coll Cardiol. 2019;73:945-947.
    >> Share

  246. VERMA S, Wanner C, Zwiener I, Ofstad AP, et al
    Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2019 Mar 5. pii: S0735-1097(19)33807.
    >> Share

  247. ARNOLD SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, et al
    Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    J Am Coll Cardiol. 2019 Mar 4. pii: S0735-1097(19)30505.
    >> Share

    February 2019
  248. ZANNAD F, Ferreira JP
    Is Sacubitril/Valsartan Antifibrotic?
    J Am Coll Cardiol. 2019;73:807-809.
    >> Share

  249. ZILE MR, O'Meara E, Claggett B, Prescott MF, et al
    Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
    J Am Coll Cardiol. 2019;73:795-806.
    >> Share

  250. GREENE SJ, Fonarow GC, DeVore AD, Sharma PP, et al
    Longitudinal Titration of Medical Therapy for Heart Failure with Reduced Ejection Fraction: CHAMP-HF Registry.
    J Am Coll Cardiol. 2019 Feb 20. pii: S0735-1097(19)30566.
    >> Share

  251. MCHUGH K, DeVore AD, Wu J, Matsouaka RA, et al
    Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:602-611.
    >> Share

    January 2019
  252. VENTURA HO, Lavie CJ, Mehra MR
    HDL and Heart Failure Regulation: Still Breathing but Exhausted.
    J Am Coll Cardiol. 2019;73:187-189.
    >> Share

  253. HUNTER WG, McGarrah RW 3rd, Kelly JP, Khouri MG, et al
    High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    J Am Coll Cardiol. 2019;73:177-186.
    >> Share

  254. WALSH MN, Jessup M, Lindenfeld J
    Women With Heart Failure: Unheard, Untreated, and Unstudied.
    J Am Coll Cardiol. 2019;73:41-43.
    >> Share

  255. DEWAN P, Rorth R, Jhund PS, Shen L, et al
    Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.
    J Am Coll Cardiol. 2019;73:29-40.
    >> Share

    December 2018
  256. FELKER GM, Ahmad T
    Biomarkers for the Prevention of Heart Failure: Are We There Yet?
    J Am Coll Cardiol. 2018;72:3255-3258.
    >> Share

  257. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    >> Share

    November 2018
  258. BOHM M, Ewen S, Wolf M
    Renal Denervation Halts Left Ventricular Remodeling and Dysfunction in Heart Failure: New Shores Ahead.
    J Am Coll Cardiol. 2018;72:2622-2624.
    >> Share

  259. SHARP TE 3RD, Polhemus DJ, Li Z, Spaletra P, et al
    Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System.
    J Am Coll Cardiol. 2018;72:2609-2621.
    >> Share

  260. BRUNNER-LA ROCCA HP, Sanders-van Wijk S
    Guiding Heart Failure Therapy After GUIDE-IT: Back to the Drawing Board.
    J Am Coll Cardiol. 2018;72:2563-2566.
    >> Share

  261. MARK DB, Cowper PA, Anstrom KJ, Sheng S, et al
    Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure.
    J Am Coll Cardiol. 2018;72:2551-2562.
    >> Share

  262. AGGARWAL M, Bozkurt B, Panjrath G, Aggarwal B, et al
    Lifestyle Modifications for Preventing and Treating Heart Failure.
    J Am Coll Cardiol. 2018;72:2391-2405.
    >> Share

  263. RICHARDS AM
    ST2 and Prognosis in Chronic Heart Failure.
    J Am Coll Cardiol. 2018;72:2321-2323.
    >> Share

  264. EMDIN M, Aimo A, Vergaro G, Bayes-Genis A, et al
    sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    J Am Coll Cardiol. 2018;72:2309-2320.
    >> Share

    October 2018
  265. JOLLY SS, Cairns JA, Lavi S, Cantor WJ, et al
    Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.
    J Am Coll Cardiol. 2018;72:1589-1596.
    >> Share

    September 2018
  266. MERKEN J, Brunner-La Rocca HP, Weerts J, Verdonschot J, et al
    Heart Failure With Recovered Ejection Fraction.
    J Am Coll Cardiol. 2018;72:1557-1558.
    >> Share

  267. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    >> Share

  268. COLANTONIO LD, Booth JN 3rd, Bress AP, Whelton PK, et al
    2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
    J Am Coll Cardiol. 2018;72:1187-1197.
    >> Share

  269. GUPTA DK, York MK, Wang TJ
    Reply: Heart Failure, Natriuretic Peptides, and Clinical Practice: Moving Beyond Binary.
    J Am Coll Cardiol. 2018;72:1180-1181.
    >> Share

  270. DIETSCHE SL, Breidthardt T, Kozhuharov N, Mueller CE, et al
    Heart Failure: It Is Not Just Yes or No.
    J Am Coll Cardiol. 2018;72:1180.
    >> Share

  271. GOYAL H, Lippi G, Hu ZD
    B-Natriuretic Peptide in Prognosis of Patients With or Without Heart Failure: Impact of Different Assays.
    J Am Coll Cardiol. 2018;72:1179-1180.
    >> Share

  272. AHMAD T, Wilson FP, Desai NR
    The Trifecta of Precision Care in Heart Failure: Biology, Biomarkers, and Big Data.
    J Am Coll Cardiol. 2018;72:1091-1094.
    >> Share

  273. TROMP J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, et al
    Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:1081-1090.
    >> Share

  274. DUPREZ DA, Jacobs DR Jr
    Lung Function Decline and Increased Cardiovascular Risk: Quo Vadis.
    J Am Coll Cardiol. 2018;72:1123-1125.
    >> Share

  275. SILVESTRE OM, Nadruz W Jr, Querejeta Roca G, Claggett B, et al
    Declining Lung Function and Cardiovascular Risk: The ARIC Study.
    J Am Coll Cardiol. 2018;72:1109-1122.
    >> Share

    August 2018
  276. LOPEZ-CANDALES A
    Impact of Left Ventricular Wall Thickness on Global Longitudinal Strain in Acute Heart Failure.
    J Am Coll Cardiol. 2018;72:1066-1067.
    >> Share

  277. HEYDARI B, Abdullah S, Shah R, Francis SA, et al
    Omega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis.
    J Am Coll Cardiol. 2018;72:953-955.
    >> Share

  278. LUPON J, Gavidia-Bovadilla G, Ferrer E, de Antonio M, et al
    Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.
    J Am Coll Cardiol. 2018;72:591-601.
    >> Share

    July 2018
  279. URIEL N, Sayer G, Annamalai S, Kapur NK, et al
    Mechanical Unloading in Heart Failure.
    J Am Coll Cardiol. 2018;72:569-580.
    >> Share

  280. ROSENSON RS, Kaul R
    Cardiovascular Outcomes in Persons With HIV and Heart Failure: Medication Class or Suboptimal Viral Suppression?
    J Am Coll Cardiol. 2018;72:531-533.
    >> Share

  281. ALVI RM, Neilan AM, Tariq N, Awadalla M, et al
    Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.
    J Am Coll Cardiol. 2018;72:518-530.
    >> Share

  282. GREENE SJ, Butler J, Albert NM, DeVore AD, et al
    Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    J Am Coll Cardiol. 2018;72:351-366.
    >> Share

  283. MENTZ RJ, Greene SJ
    Adding Troponin to the Puzzle of Heart Failure With Preserved Ejection Fraction: Marker or Mediator?
    J Am Coll Cardiol. 2018;72:41-44.
    >> Share

  284. OBOKATA M, Reddy YNV, Melenovsky V, Kane GC, et al
    Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2018;72:29-40.
    >> Share

    June 2018
  285. FELKER GM, Fudim M
    Unraveling the Mystery of Troponin Elevation in Heart Failure.
    J Am Coll Cardiol. 2018;71:2917-2918.
    >> Share

  286. LICHSTEIN E, Sharma A
    Changing Endpoints for Heart Failure Studies.
    J Am Coll Cardiol. 2018;71:2653-2655.
    >> Share

  287. GREENE SJ, O'Brien EC, Mentz RJ, Luo N, et al
    Home-Time After Discharge Among Patients Hospitalized With Heart Failure.
    J Am Coll Cardiol. 2018;71:2643-2652.
    >> Share

  288. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    >> Share

  289. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    >> Share

  290. FARKOUH ME, Verma S
    Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL.
    J Am Coll Cardiol. 2018;71:2507-2510.
    >> Share

    May 2018
  291. VODOVAR N, Logeart D
    Similar BNP and Mortality Association in Patients With and Without Heart Failure: Any Increase Matters.
    J Am Coll Cardiol. 2018;71:2089-2091.
    >> Share

  292. YORK MK, Gupta DK, Reynolds CF, Farber-Eger E, et al
    B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    J Am Coll Cardiol. 2018;71:2079-2088.
    >> Share

  293. PARK JJ, Park JB, Park JH, Cho GY, et al
    Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2018;71:1947-1957.
    >> Share

  294. GORODESKI EZ, Goyal P, Hummel SL, Krishnaswami A, et al
    Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.
    J Am Coll Cardiol. 2018;71:1921-1936.
    >> Share

    April 2018
  295. GONZALEZ A, Schelbert EB, Diez J, Butler J, et al
    Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.
    J Am Coll Cardiol. 2018;71:1696-1706.
    >> Share

  296. BOFFETTA P, Malhotra J
    Impact of Heart Failure on Cancer Incidence: A Complicated Question.
    J Am Coll Cardiol. 2018;71:1511-1512.
    >> Share

  297. SELVARAJ S, Bhatt DL, Claggett B, Djousse L, et al
    Lack of Association Between Heart Failure and Incident Cancer.
    J Am Coll Cardiol. 2018;71:1501-1510.
    >> Share

    March 2018
  298. PATANE S
    Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397.
    >> Share

  299. VAN VARK LC, Kardys I, Boersma E, Hillege HL, et al
    Reply: Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397-1398.
    >> Share

  300. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    >> Share

  301. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    >> Share

  302. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    >> Share

  303. KUMMEN M, Mayerhofer CCK, Vestad B, Broch K, et al
    Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.
    J Am Coll Cardiol. 2018;71:1184-1186.
    >> Share

  304. LAUTEN A, Dreger H, Schofer J, Grube E, et al
    Caval Valve Implantation for Treatment of Severe Tricuspid Regurgitation.
    J Am Coll Cardiol. 2018;71:1183-1184.
    >> Share

  305. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    >> Share

  306. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    >> Share

    February 2018
  307. BAJAJ NS, Patel N, Prabhu SD, Arora G, et al
    Effect of NT-proBNP-Guided Therapy on All-Cause Mortality in Chronic Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2018;71:951-952.
    >> Share

  308. SANO S, Oshima K, Wang Y, MacLauchlan S, et al
    Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1beta/NLRP3 Inflammasome.
    J Am Coll Cardiol. 2018;71:875-886.
    >> Share

  309. ROCHA BML, Cunha GJL, Menezes Falcao LF
    The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
    J Am Coll Cardiol. 2018;71:782-793.
    >> Share

  310. BORNE Y, Gransbo K, Nilsson J, Melander O, et al
    Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart Failure.
    J Am Coll Cardiol. 2018;71:580-582.
    >> Share

    January 2018
  311. O'CONNOR CM, Psotka MA, Fiuzat M, Lindenfeld J, et al
    Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.
    J Am Coll Cardiol. 2018;71:443-453.
    >> Share

  312. TROUGHTON RW, Frampton CMA
    Can Biomarker Panels Predict Response to Pharmacotherapy in Heart Failure?
    J Am Coll Cardiol. 2018;71:399-401.
    >> Share

  313. OUWERKERK W, Zwinderman AH, Ng LL, Demissei B, et al
    Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    J Am Coll Cardiol. 2018;71:386-398.
    >> Share

  314. MARWICK TH, Ritchie R, Shaw JE, Kaye D, et al
    Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2018;71:339-351.
    >> Share

  315. QURESHI WT, Zhang ZM, Chang PP, Rosamond WD, et al
    Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    J Am Coll Cardiol. 2018;71:1-8.
    >> Share

  316. GIBSON CM, Nafee T, Kerneis M
    Silent Myocardial Infarction: Listen to the Evidence.
    J Am Coll Cardiol. 2018;71:9-11.
    >> Share

    December 2017
  317. SCHUETT K, Kleber ME, Scharnagl H, Lorkowski S, et al
    Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3202-3204.
    >> Share

  318. LOGSTRUP BB, Ellingsen T, Pedersen AB, Kjaersgaard A, et al
    Heart Failure and Ischemic Heart Disease in Patients With Rheumatoid Arthritis.
    J Am Coll Cardiol. 2017;70:3069-3071.
    >> Share

  319. STEINER J, Rodes-Cabau J, Holmes DR Jr, LeWinter MM, et al
    Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3026-3041.
    >> Share

  320. YANCY CW, Januzzi JL Jr, Allen LA, Butler J, et al
    2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017 Dec 13. pii: S0735-1097(17)41641.
    >> Share

  321. MCCRINK KA, Maning J, Vu A, Jafferjee M, et al
    Cardiac betaarrestin2 Improves Contractility and Adverse Remodeling in Heart Failure, But Is Underexpressed in Humans.
    J Am Coll Cardiol. 2017;70:2948-2949.
    >> Share

  322. FARRIS SD, Stempien-Otero A
    Reply: Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2838-2839.
    >> Share

  323. DIAS NOVAES R
    Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2837-2838.
    >> Share

  324. ERGLIS A, Narbute I, Poupineau M, Hovasse T, et al
    Treatment of Secondary Mitral Regurgitation in Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:2834-2835.
    >> Share

  325. LAVIE CJ, Milani RV, Ventura HO
    Adipose Composition and Heart Failure Prognosis: Paradox or Not?
    J Am Coll Cardiol. 2017;70:2750-2751.
    >> Share

  326. TSUJIMOTO T, Kajio H
    Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
    J Am Coll Cardiol. 2017;70:2739-2749.
    >> Share

    November 2017
  327. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    >> Share

  328. REDDY YNV, Borlaug BA
    Reply: Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458-2459.
    >> Share

  329. MESSERLI FH, Rimoldi SF, Wilhelm M
    Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458.
    >> Share

  330. BAYES-GENIS A, Nunez J, Lupon J
    Soluble ST2 for Prognosis and Monitoring in Heart Failure: The New Gold Standard?
    J Am Coll Cardiol. 2017;70:2389-2392.
    >> Share

  331. VAN VARK LC, Lesman-Leegte I, Baart SJ, Postmus D, et al
    Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2017;70:2378-2388.
    >> Share

    October 2017
  332. PARIKH NI, Hall PS
    Reply: Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2313.
    >> Share

  333. EL-BATTRAWY I, Borggrefe M, Akin I
    Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2312-2313.
    >> Share

  334. STEINBERG BA, Fang JC
    Long-Term Outcomes of Acute Heart Failure: Where Are We Now?
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39762.
    >> Share

  335. SHAH KS, Xu H, Matsouaka RA, Bhatt DL, et al
    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39761.
    >> Share

  336. LEWIS GA, Schelbert EB, Williams SG, Cunnington C, et al
    Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2186-2200.
    >> Share

  337. PASCUAL-FIGAL DA
    Neprilysin and Heart Failure: A "Sympathetic" Relationship?
    J Am Coll Cardiol. 2017;70:2154-2156.
    >> Share

  338. FRANCIS GS
    Cholesterol and Heart Failure: Is There an Important Connection?
    J Am Coll Cardiol. 2017;70:2137-2138.
    >> Share

  339. BAYES-GENIS A, Nunez J, Zannad F, Ferreira JP, et al
    The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.
    J Am Coll Cardiol. 2017;70:2128-2136.
    >> Share

  340. POLHEMUS DJ, Trivedi RK, Gao J, Li Z, et al
    Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
    J Am Coll Cardiol. 2017;70:2139-2153.
    >> Share

  341. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Reply: Preterm Birth and Risk of Heart Failure in Childhood and Early Adulthood.
    J Am Coll Cardiol. 2017;70:1944-1945.
    >> Share

  342. BASSAREO PP, Namana V, Fanos V, Mercuro G, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;70:1943-1944.
    >> Share

  343. KAVALIERATOS D, Gelfman LP, Tycon LE, Riegel B, et al
    Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.
    J Am Coll Cardiol. 2017;70:1919-1930.
    >> Share

  344. KLEIN L
    (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure.
    J Am Coll Cardiol. 2017;70:1887-1889.
    >> Share

  345. GIVERTZ MM, Stevenson LW, Costanzo MR, Bourge RC, et al
    Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1875-1886.
    >> Share

  346. LAM PH, Dooley DJ, Deedwania P, Singh SN, et al
    Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1861-1871.
    >> Share

  347. SCHERRER U, Rexhaj E, Soria R, Meister TA, et al
    Preterm Birth and Risk of Heart Failure: Potential Contribution of Assisted Reproductive Technologies.
    J Am Coll Cardiol. 2017;70:1828-1829.
    >> Share

  348. WATANABE S, Ishikawa K, Fish K, Oh JG, et al
    Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;70:1744-1756.
    >> Share

    September 2017
  349. LI JG, Xu H
    Should Beta-Blockers Be Routinely Prescribed for Myocardial Infarction Without Heart Failure or Ventricular Dysfunction?
    J Am Coll Cardiol. 2017;70:1685-1686.
    >> Share

  350. GUAZZI M, Bandera F, Ozemek C, Systrom D, et al
    Cardiopulmonary Exercise Testing: What Is its Value?
    J Am Coll Cardiol. 2017;70:1618-1636.
    >> Share

  351. EL-BATTRAWY I, Borggrefe M, Akin I
    beta-Blockers and Outcome After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;70:1685.
    >> Share

  352. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    >> Share

  353. SIVAGNANAM K, Mendes LA, Schlendorf KH, Damp JB, et al
    Bridge to Transplantation: Advanced Heart Failure and Transplant Cardiology Training for Cardiovascular Disease Fellows.
    J Am Coll Cardiol. 2017;70:1413-1416.
    >> Share

  354. FLORAS JS
    Ambulatory Apnea Monitoring in Heart Failure: Proceed With Caution.
    J Am Coll Cardiol. 2017;70:1365-1367.
    >> Share

  355. EMDIN M, Mirizzi G, Giannoni A, Poletti R, et al
    Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:1351-1364.
    >> Share

  356. LIPSHULTZ SE, Barach PR, Wilkinson JD
    Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure?
    J Am Coll Cardiol. 2017;70:1273-1275.
    >> Share

  357. BONNET D, Berger F, Jokinen E, Kantor PF, et al
    Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:1262-1272.
    >> Share

    August 2017
  358. TRAVERS JG, Kamal FA, Valiente-Alandi I, Nieman ML, et al
    Pharmacological and Activated Fibroblast Targeting of Gbetagamma-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    J Am Coll Cardiol. 2017;70:958-971.
    >> Share

  359. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    >> Share

  360. ONAT A, Ozbek M, Hayiroglu MI
    Rheumatoid Arthritis and Risk of Nonischemic Heart Failure: Closely Related Common Soil.
    J Am Coll Cardiol. 2017;70:687-688.
    >> Share

    July 2017
  361. ABDULHADI B, Mezue K, Rangaswami J
    Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408.
    >> Share

  362. KONSTAM MA, Udelson JE
    Reply: Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408-409.
    >> Share

  363. ABRAHAM WT, Perl L
    Implantable Hemodynamic Monitoring for Heart Failure Patients.
    J Am Coll Cardiol. 2017;70:389-398.
    >> Share

  364. FARRIS SD, Don C, Helterline D, Costa C, et al
    Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    J Am Coll Cardiol. 2017;70:344-354.
    >> Share

  365. ROGERS JG, Patel CB, Mentz RJ, Granger BB, et al
    Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
    J Am Coll Cardiol. 2017;70:331-341.
    >> Share

  366. BUTLER J, Skopicki H
    Quest for Pathophysiological Understanding of Heart Failure With Preserved Ejection Fraction: Stiffened Resolve, Compliant Approach.
    J Am Coll Cardiol. 2017;70:149-151.
    >> Share

  367. REDDY YNV, Andersen MJ, Obokata M, Koepp KE, et al
    Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:136-148.
    >> Share

  368. MUNZEL T, Camici GG, Maack C, Bonetti NR, et al
    Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:212-229.
    >> Share

  369. CANNAVO A, Rengo G, Liccardo D, Pun A, et al
    beta1-Blockade Prevents Post-Ischemic Myocardial Decompensation Via beta3AR-Dependent Protective Sphingosine-1 Phosphate Signaling.
    J Am Coll Cardiol. 2017;70:182-192.
    >> Share

    June 2017
  370. MATSUE Y, Damman K, Voors AA, Kagiyama N, et al
    Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:3042-3051.
    >> Share

  371. SOLOMON SD, Desai AS
    Acute Heart Failure: One Syndrome or Many?
    J Am Coll Cardiol. 2017;69:3040-3041.
    >> Share

  372. GREENE SJ, Hernandez AF, Dunning A, Ambrosy AP, et al
    Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    J Am Coll Cardiol. 2017;69:3029-3039.
    >> Share

  373. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    >> Share

  374. PINNEY SP, Anyanwu AC, Lala A, Teuteberg JJ, et al
    Left Ventricular Assist Devices for Lifelong Support.
    J Am Coll Cardiol. 2017;69:2845-2861.
    >> Share

  375. DONDO TB, Hall M, West RM, Jernberg T, et al
    beta-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
    J Am Coll Cardiol. 2017;69:2710-2720.
    >> Share

    May 2017
  376. LEESON P, Lewandowski AJ
    A New Risk Factor for Early Heart Failure: Preterm Birth.
    J Am Coll Cardiol. 2017;69:2643-2645.
    >> Share

  377. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;69:2634-2642.
    >> Share

  378. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    >> Share

  379. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    >> Share

  380. BHATT AS, DeVore AD, DeWald TA, Swedberg K, et al
    Achieving a Maximally Tolerated beta-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
    J Am Coll Cardiol. 2017;69:2542-2550.
    >> Share

  381. SCOTT NS
    Understanding Hormones, Menopause, and Heart Failure: Still a Work in Progress.
    J Am Coll Cardiol. 2017;69:2527-2529.
    >> Share

  382. HALL PS, Nah G, Howard BV, Lewis CE, et al
    Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative.
    J Am Coll Cardiol. 2017;69:2517-2526.
    >> Share

  383. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    >> Share

  384. COSTANZO MR, Ronco C, Abraham WT, Agostoni P, et al
    Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research.
    J Am Coll Cardiol. 2017;69:2428-2445.
    >> Share

  385. ZEITLER EP, Friedman DJ, Daubert JP, Al-Khatib SM, et al
    Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;69:2369-2379.
    >> Share

  386. KOSMALA W, Marwick TH
    Reply: Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2352-2353.
    >> Share

  387. PEVERILL RE, Gelman JS
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2351-2352.
    >> Share

  388. KOSMALA W, Marwick TH
    Reply: The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2351.
    >> Share

  389. PAN A
    The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2350-2351.
    >> Share

  390. REDDY VY, Miller MA, Neuzil P, Sogaard P, et al
    Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study.
    J Am Coll Cardiol. 2017;69:2119-2129.
    >> Share

    April 2017
  391. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
    J Am Coll Cardiol. 2017 Apr 21. pii: S0735-1097(17)37087.
    >> Share

  392. MENACHEM JN
    Advanced Heart Failure in the ACHD Population: Finding the Fellows' Role in a Growing Field.
    J Am Coll Cardiol. 2017;69:1986-1989.
    >> Share

  393. JAKOVLJEVIC DG, Yacoub MH, Schueler S, MacGowan GA, et al
    Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1924-1933.
    >> Share

  394. ANDERSEN OS, Smiseth OA, Dokainish H, Abudiab MM, et al
    Estimating Left Ventricular Filling Pressure by Echocardiography.
    J Am Coll Cardiol. 2017;69:1937-1948.
    >> Share

  395. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    >> Share

  396. KOTECHA D, Flather MD, Altman DG, Holmes J, et al
    Heart Rate, Heart Rhythm, and Prognostic Benefits of Beta-Blockers in Heart Failure: Individual Patient-Data Meta-Analysis.
    J Am Coll Cardiol. 2017 Apr 5. pii: S0735-1097(17)36893.
    >> Share

  397. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    >> Share

  398. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    >> Share

  399. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    >> Share

    March 2017
  400. HAVAKUK O, King KS, Grazette L, Yoon AJ, et al
    Heart Failure-Induced Brain Injury.
    J Am Coll Cardiol. 2017;69:1609-1616.
    >> Share

  401. FANG JC, Vidic A
    Central Sleep Apnea in Heart Failure: Sleeping With the Wrong Enemy?
    J Am Coll Cardiol. 2017;69:1588-1591.
    >> Share

  402. O'CONNOR CM, Whellan DJ, Fiuzat M, Punjabi NM, et al
    Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.
    J Am Coll Cardiol. 2017;69:1577-1587.
    >> Share

  403. YANCY CW
    Acute Heart Failure: Searching for a New Evident Truth.
    J Am Coll Cardiol. 2017;69:1420-1423.
    >> Share

  404. KONSTAM MA, Kiernan M, Chandler A, Dhingra R, et al
    Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2017;69:1409-1419.
    >> Share

  405. MITTER SS, Shah SJ, Thomas JD
    A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure.
    J Am Coll Cardiol. 2017;69:1451-1464.
    >> Share

  406. KRUMHOLZ HM, Dhruva SS
    Real World Data on Heart Failure Readmission Reduction: Real or Real Uncertain?
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36043.
    >> Share

  407. HEIDENREICH P
    Inflammation and Heart Failure: Therapeutic or Diagnostic Opportunity?
    J Am Coll Cardiol. 2017;69:1286-1287.
    >> Share

  408. MANTEL A, Holmqvist M, Andersson DC, Lund LH, et al
    Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;69:1275-1285.
    >> Share

  409. DESAI AS, Bhimaraj A, Bharmi R, Jermyn R, et al
    Reduction in Heart Failure Hospitalizations With Ambulatory Hemodynamic Monitoring Seen in Clinical Trials Is Maintained in the 'Real World'.
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)35978.
    >> Share

  410. PANDEY A, LaMonte M, Klein L, Ayers C, et al
    Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.
    J Am Coll Cardiol. 2017;69:1129-1142.
    >> Share

  411. JESSUP M, Drazner MH, Book W, Cleveland JC Jr, et al
    2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac T
    J Am Coll Cardiol. 2017 Mar 3. pii: S0735-1097(17)30791.
    >> Share

    February 2017
  412. NAGATOMO Y, McNamara DM, Alexis JD, Cooper LT, et al
    Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against beta1-Adrenergic Receptors.
    J Am Coll Cardiol. 2017;69:968-977.
    >> Share

  413. JANUZZI JL JR, Ibrahim NE
    Renin-Angiotensin System Blockade in Heart Failure: More to the Picture Than Meets the Eye.
    J Am Coll Cardiol. 2017;69:820-822.
    >> Share

  414. BASU R, Poglitsch M, Yogasundaram H, Thomas J, et al
    Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    J Am Coll Cardiol. 2017;69:805-819.
    >> Share

  415. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    >> Share

  416. BAVISHI C, Bangalore S, Messerli FH
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;69:486-493.
    >> Share

    January 2017
  417. GOLDSMITH SR
    Future Study With Tolvaptan in Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:467.
    >> Share

  418. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    >> Share

  419. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:364-365.
    >> Share

  420. SHAH R
    Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:363-364.
    >> Share

  421. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    >> Share

  422. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    >> Share

  423. VAN KIMMENADE RR, Ten Cate TJ, Brunner-La Rocca HP
    Worsening Renal Function in Heart Failure: It Takes 2 to Tangle.
    J Am Coll Cardiol. 2017;69:70-72.
    >> Share

  424. NG LL, Squire IB, Jones DJ, Cao TH, et al
    Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    J Am Coll Cardiol. 2017;69:56-69.
    >> Share

  425. REDDY YN, Borlaug BA
    Reply: High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:113-114.
    >> Share

  426. CERIT L, Kemal H, Gunsel A, Duygu H, et al
    High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:112-113.
    >> Share

  427. JANJUA SA, Triant VA, Addison D, Szilveszter B, et al
    HIV Infection and Heart Failure Outcomes in Women.
    J Am Coll Cardiol. 2017;69:107-108.
    >> Share

    December 2016
  428. PAVO N, Wurm R, Goliasch G, Novak JF, et al
    Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2912-2914.
    >> Share

  429. CARBONE S, Canada JM, Buckley LF, Trankle CR, et al
    Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2487-2488.
    >> Share

  430. MCKIE PM, Burnett JC Jr
    NT-proBNP: The Gold Standard Biomarker in Heart Failure.
    J Am Coll Cardiol. 2016;68:2437-2439.
    >> Share

  431. ZILE MR, Claggett BL, Prescott MF, McMurray JJ, et al
    Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
    J Am Coll Cardiol. 2016;68:2425-2436.
    >> Share

    November 2016
  432. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    >> Share

  433. HE GH, Xu GL, Cai WK, Zhang J, et al
    Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029.
    >> Share

  434. LEARY PJ, Bristow MR
    Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029-2030.
    >> Share

  435. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    >> Share

  436. HALL S, Uriel N, Carey S, Edens M, et al
    TCT-122 Use of the Impella 5.0 circulatory support device for bridge to decision during acute decompensation of advanced heart failure.
    J Am Coll Cardiol. 2016;68.
    >> Share

  437. PARK Y, Rha SW, Choi BG, Byun JK, et al
    TCT-817 High-Sensitivity C-reactive Protein Predicts New-Onset Heart Failure in Patients Treated with Moderate-Intensity Statin for Primary Prevention.
    J Am Coll Cardiol. 2016;68.
    >> Share

  438. VAN GILS L, Clavel MA, Vollema M, Delgado V, et al
    TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  439. ANSARI M, Garcia D
    TCT-766 Catheter-Guided Renal Denervation Used For The Treatment Of Heart Failure With Reduced Ejection Fraction: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    >> Share

  440. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    >> Share

  441. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    >> Share

  442. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    >> Share

  443. STONE G, Abraham W, Lindenfeld J, Weissman N, et al
    TCT-627 Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients with Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort.
    J Am Coll Cardiol. 2016;68.
    >> Share

    October 2016
  444. KOSMALA W, Rojek A, Przewlocka-Kosmala M, Wright L, et al
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:1823-1834.
    >> Share

  445. WEVER-PINZON J, Selzman CH, Stoddard G, Wever-Pinzon O, et al
    Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    J Am Coll Cardiol. 2016;68:1741-1752.
    >> Share

  446. SARWAR CM, Papadimitriou L, Pitt B, Pina I, et al
    Hyperkalemia in Heart Failure.
    J Am Coll Cardiol. 2016;68:1575-89.
    >> Share

  447. GUPTA SK, Foinquinos A, Thum S, Remke J, et al
    Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:1557-71.
    >> Share

    September 2016
  448. MAISEL AS, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
    J Am Coll Cardiol. 2016;68:1420-31.
    >> Share

  449. VON HAEHLING S, Hasenfuss G, Anker SD
    Diabetes and Heart Failure: Sugared Words Prove Bitter.
    J Am Coll Cardiol. 2016;68:1417-9.
    >> Share

  450. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    >> Share

  451. WARING AA, Litwin SE
    Redefining Reverse Remodeling: Can Echocardiography Refine Our Ability to Assess Response to Heart Failure Treatments?
    J Am Coll Cardiol. 2016;68:1277-80.
    >> Share

  452. STARLING RC, Young JB
    Tolvaptan in Acute Heart Failure: Time to Move On.
    J Am Coll Cardiol. 2016 Sep 15. pii: S0735-1097(16)35324.
    >> Share

  453. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    >> Share

  454. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    >> Share

  455. FELKER GM, Mentz RJ, Cole R, Adams KF, et al
    Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure.
    J Am Coll Cardiol. 2016 Sep 13. pii: S0735-1097(16)35321.
    >> Share

    July 2016
  456. OPITZ CF, Hoeper MM, Gibbs JS, Kaemmerer H, et al
    Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
    J Am Coll Cardiol. 2016;68:368-78.
    >> Share

  457. BEN-YEHUDA O, Rubin LJ
    Pulmonary Hypertension Overlap Syndromes: A Real Entity?
    J Am Coll Cardiol. 2016;68:379-81.
    >> Share

    June 2016
  458. SORAJJA P, Pedersen WA, Bae R, Lesser JR, et al
    First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:2811-8.
    >> Share

    May 2016
  459. BARON SJ, Arnold SV, Herrmann HC, Holmes DR Jr, et al
    Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;67:2349-58.
    >> Share

  460. NAPPI F, Lusini M, Spadaccio C, Nenna A, et al
    Papillary Muscle Approximation Versus Restrictive Annuloplasty Alone for Severe Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2016;67:2334-46.
    >> Share

  461. EGBE AC, Luis SA, Padang R, Warnes CA, et al
    Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?
    J Am Coll Cardiol. 2016;67:2321-9.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016